{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T12:37:47Z","timestamp":1758631067735},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,3,24]],"date-time":"2009-03-24T00:00:00Z","timestamp":1237852800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s00417-009-1067-9","type":"journal-article","created":{"date-parts":[[2009,3,23]],"date-time":"2009-03-23T12:27:39Z","timestamp":1237811259000},"page":"899-906","source":"Crossref","is-referenced-by-count":19,"title":["One-year results of combined photodynamic therapy and intravitreal bevacizumab injection for retinal pigment epithelial detachment secondary to age-related macular degeneration"],"prefix":"10.1007","volume":"247","author":[{"given":"Chiharu","family":"Shima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumi","family":"Gomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motokazu","family":"Tsujikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Tano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,3,24]]},"reference":[{"key":"1067_CR1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/archopht.122.4.453","volume":"122","author":"R Axer-Siegel","year":"2004","unstructured":"Axer-Siegel R, Ehrlich R, Rosenblatt I, Kramer M, Priel E, Yassur Y, Weinberger D (2004) Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration. Arch Ophthalmol 122:453\u2013459, doi: 10.1001\/archopht.122.4.453","journal-title":"Arch Ophthalmol"},{"key":"1067_CR2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00006982-199414020-00003","volume":"14","author":"LA Yannuzzi","year":"1994","unstructured":"Yannuzzi LA, Hope-Ross M, Slakter JS, Guyer DR, Sorenson JA, Ho AC, Sperber DE, Freund KB, Orlock DA (1994) Analysis of vascularized pigment epithelial detachments using indocyanine green videoangiography. Retina 14:99\u2013113, doi: 10.1097\/00006982-199414020-00003","journal-title":"Retina"},{"key":"1067_CR3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ajo.2006.08.025","volume":"143","author":"A Tsujikawa","year":"2007","unstructured":"Tsujikawa A, Sasahara M, Otani A, Gotoh N, Kameda T, Iwama D, Yodoi Y, Tamura H, Mandai M, Yoshimura N (2007) Pigment epithelial detachment in polypoidal choroidal vasculopathy. Am J Ophthalmol 143:102\u2013111, doi: 10.1016\/j.ajo.2006.08.025","journal-title":"Am J Ophthalmol"},{"key":"1067_CR4","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/00006982-200110000-00003","volume":"21","author":"LA Yannuzzi","year":"2001","unstructured":"Yannuzzi LA, Negr\u00e3o S, Iida T, Carvalho C, Rodriguez-Coleman H, Slakter J, Freund KB, Sorenson J, Orlock D, Borodoker N (2001) Retinal angiomatous proliferation in age-related macular degeneration. Retina 21:416\u2013434, doi: 10.1097\/00006982-200110000-00003","journal-title":"Retina"},{"key":"1067_CR5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0002-9394(79)90659-7","volume":"88","author":"TA Meredith","year":"1979","unstructured":"Meredith TA, Braley RE, Aaberg TM (1979) Natural history of serous detachments of the retinal pigment epithelium. Am J Ophthalmol 88:643\u2013651","journal-title":"Am J Ophthalmol"},{"key":"1067_CR6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/bjo.65.6.417","volume":"65","author":"A Hoskin","year":"1981","unstructured":"Hoskin A, Bird AC, Sehmi K (1981) Tears of detached retinal pigment epithelium. Br J Ophthalmol 65:417\u2013422, doi: 10.1136\/bjo.65.6.417","journal-title":"Br J Ophthalmol"},{"key":"1067_CR7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00417-002-0505-8","volume":"240","author":"D Pauleikhoff","year":"2002","unstructured":"Pauleikhoff D, L\u00f6ffert D, Spital G, Radermacher M, Dohrmann J, Lommatzsch A, Bird AC (2002) Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol 240:533\u2013538, doi: 10.1007\/s00417-002-0505-8","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1067_CR8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0002-9394(01)00967-9","volume":"131","author":"Verteporfin In Photodynamic Therapy Study Group","year":"2001","unstructured":"Verteporfin In Photodynamic Therapy Study Group (2001) Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization\u2013verteporfin in photodynamic therapy report 2. Am J Ophthalmol 131:541\u2013560, doi: 10.1016\/S0002-9394(01)00967-9","journal-title":"Am J Ophthalmol"},{"key":"1067_CR9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3928\/15428877-20061101-02","volume":"37","author":"R Axer-Siegel","year":"2006","unstructured":"Axer-Siegel R, Ehrlich R, Avisar I, Kramer M, Rosenblatt I, Priel E, Weinberger D (2006) Combined photodynamic therapy and intravitreal triamcinolone acetonide injection for neovascular age-related macular degeneration with pigment epithelium detachment. Ophthalmic Surg Lasers Imaging 37:455\u2013461","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"1067_CR10","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.ophtha.2007.03.006","volume":"114","author":"R Lazic","year":"2007","unstructured":"Lazic R, Gabric N (2007) Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration. Ophthalmology 114:1179\u20131185, doi: 10.1016\/j.ophtha.2007.03.006","journal-title":"Ophthalmology"},{"key":"1067_CR11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/01.iae.0000225766.75009.3a","volume":"26","author":"RM Rich","year":"2006","unstructured":"Rich RM, Rosenfeld PJ, Puliafito CA, Dubovy SR, Davis JL, Flynn HW Jr, Gonzalez S, Feuer WJ, Lin RC, Lalwani GA, Nguyen JK, Kumar G (2006) Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina 26:495\u2013511, doi: 10.1097\/01.iae.0000225766.75009.3a","journal-title":"Retina"},{"key":"1067_CR12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2005.11.019","volume":"113","author":"RL Avery","year":"2006","unstructured":"Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ (2006) Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113:363\u2013372, doi: 10.1016\/j.ophtha.2005.11.019","journal-title":"Ophthalmology"},{"key":"1067_CR13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00417-006-0466-4","volume":"245","author":"R Lazic","year":"2007","unstructured":"Lazic R, Gabric N (2007) Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 245:68\u201373, doi: 10.1007\/s00417-006-0466-4","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1067_CR14","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/bjo.2006.102467","volume":"91","author":"M Bolz","year":"2007","unstructured":"Bolz M, Michels S, Geitzenauer W, Prager F, Schmidt-Erfurth U (2007) Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment. Br J Ophthalmol 91:785\u2013789, doi: 10.1136\/bjo.2006.102467","journal-title":"Br J Ophthalmol"},{"key":"1067_CR15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/01.iae.0000249574.89437.40","volume":"27","author":"E Chen","year":"2007","unstructured":"Chen E, Kaiser RS, Vander JF (2007) Intravitreal bevacizumab for refractory pigment epithelial detachment with occult choroidal neovascularization in age-related macular degeneration. Retina 27:445\u2013450, doi: 10.1097\/01.iae.0000249574.89437.40","journal-title":"Retina"},{"key":"1067_CR16","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/IAE.0b013e3180ca9ad9","volume":"27","author":"ID Ladas","year":"2007","unstructured":"Ladas ID, Kotsolis AI, Papakostas TD, Rouvas AA, Karagiannis DA, Vergados I (2007) Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration. Retina 27:891\u2013896","journal-title":"Retina"},{"key":"1067_CR17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajo.2007.03.047","volume":"144","author":"I Maruko","year":"2007","unstructured":"Maruko I, Iida T, Saito M, Nagayama D, Saito K (2007) Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 144:15\u201322, doi: 10.1016\/j.ajo.2007.03.047","journal-title":"Am J Ophthalmol"},{"key":"1067_CR18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ophtha.2007.02.031","volume":"115","author":"F Gomi","year":"2008","unstructured":"Gomi F, Ohji M, Sayanagi K, Sawa M, Sakaguchi H, Oshima Y, Ikuno Y, Tano Y (2008) One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Ophthalmology 115:141\u2013146, doi: 10.1016\/j.ophtha.2007.02.031","journal-title":"Ophthalmology"},{"key":"1067_CR19","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/archopht.117.10.1329","volume":"117","author":"Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group","year":"1999","unstructured":"Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials\u2013TAP report. Arch Ophthalmol 117:1329\u20131345","journal-title":"Arch Ophthalmol"},{"key":"1067_CR20","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ajo.2007.01.028","volume":"143","author":"AE Fung","year":"2007","unstructured":"Fung AE, Lalwani GA, Rosenfeld PJ, Dubovy SR, Michels S, Feuer WJ, Puliafito CA, Davis JL, Flynn HW Jr, Esquiabro M (2007) An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 143:566\u2013583, doi: 10.1016\/j.ajo.2007.01.028","journal-title":"Am J Ophthalmol"},{"key":"1067_CR21","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/IAE.0b013e318030ea80","volume":"27","author":"CB Meyerle","year":"2007","unstructured":"Meyerle CB, Freund KB, Iturralde D, Spaide RF, Sorenson JA, Slakter JS, Klancnik JM Jr, Fisher YL, Cooney MJ, Yannuzzi LA (2007) Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation. Retina 27:451\u2013457, doi: 10.1097\/IAE.0b013e318030ea80","journal-title":"Retina"},{"key":"1067_CR22","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s00417-007-0580-y","volume":"24","author":"S Joeres","year":"2007","unstructured":"Joeres S, Heussen FM, Treziak T, Bopp S, Joussen AM (2007) Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 24:1597\u20131602, doi: 10.1007\/s00417-007-0580-y","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1067_CR23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/bjo.2007.122283","volume":"92","author":"F Gomi","year":"2008","unstructured":"Gomi F, Sawa M, Sakaguchi H, Tsujikawa M, Oshima Y, Kamei M, Tano Y (2008) Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy. Br J Ophthalmol 92:70\u201373, doi: 10.1136\/bjo.2007.122283","journal-title":"Br J Ophthalmol"},{"key":"1067_CR24","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0002-9394(03)00576-2","volume":"136","author":"Japanese Age-Related Macular Degeneration Trial (JAT) Study Group","year":"2003","unstructured":"Japanese Age-Related Macular Degeneration Trial (JAT) Study Group (2003) Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol 136:1049\u20131061, doi: 10.1016\/S0002-9394(03)00576-2","journal-title":"Am J Ophthalmol"},{"key":"1067_CR25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00006982-200304000-00004","volume":"23","author":"RA Costa","year":"2003","unstructured":"Costa RA, Farah ME, Cardillo JA, Calucci D, Williams GA (2003) Immediate indocyanine green angiography and optical coherence tomography evaluation after photodynamic therapy for subfoveal choroidal neovascularization. Retina 23:159\u2013165, doi: 10.1097\/00006982-200304000-00004","journal-title":"Retina"},{"key":"1067_CR26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/IAE.0b013e3180cc2612","volume":"27","author":"CK Chan","year":"2007","unstructured":"Chan CK, Meyer CH, Gross JG, Abraham P, Nuthi AS, Kokame GT, Lin SG, Rauser ME, Kaiser PK (2007) Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Retina 27:541\u2013551, doi: 10.1097\/IAE.0b013e3180cc2612","journal-title":"Retina"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-009-1067-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-009-1067-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-009-1067-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T00:56:44Z","timestamp":1589677004000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-009-1067-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,24]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["1067"],"URL":"https:\/\/doi.org\/10.1007\/s00417-009-1067-9","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"type":"print","value":"0721-832X"},{"type":"electronic","value":"1435-702X"}],"subject":[],"published":{"date-parts":[[2009,3,24]]}}}